Helius Medical Technologies Inc Class A (HSDT) Peer Comparison

$2.07

$-0.19 (-8.41%)

As on 30-Oct-2026 13:33EDT

Market cap

$147 Mln

Revenue (TTM)

$12 Mln

P/E Ratio

0

P/B Ratio

0.8

Div. Yield

0 %

Edit

	Helius Medical Technologies Inc Class A (HSDT)	Penumbra (PEN)	Avantor (AVTR)	Repligen (RGEN)	Glaukos Corp (GKOS)
Market cap ($ Mln)	147	12,682	10,876	11,233	14,302
Revenue ($ Mln)	12	1,560	6,636	785	690
Net Profit ($ Mln)	-157.27	157.02	337.20	41.54	-169.80
Net Margin (%)	-1,302.78	10.06	5.08	5.29	-24.60
RoE (%)	-67.42	10.27	5.90	1.97	-24.46
Price to Earnings	0.04	79.11	32.10	242.37	--
Price-To-Book	0.82	8.19	1.94	4.41	20.01

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Helius Medical Technologies Inc Class A (HSDT)	Penumbra (PEN)	Avantor (AVTR)	Repligen (RGEN)	Glaukos Corp (GKOS)
Operating Revenue	12.07	1,560.33	6,635.60	785.10	690.33
Cost of Revenue	0.54	499.55	4,539.20	384.30	130.29
Gross Profit	5.52	942.44	2,139.40	347.62	393.22
Operating Expenses	35.73	871.54	1,593.70	335.50	623.34
Operating Profit (EBIT)	-24.20	189.25	502.70	65.30	-63.30
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	-157.27	207.82	315.50	52.15	-174.52
Provision for Tax	0.00	50.81	-21.70	10.61	-4.72
Profit after Tax (Net Income)	-157.27	157.02	337.20	41.54	-169.80
Minority Interest	0.00	0.00	0.00	0.00	0.00
Consolidated Profit	0.00	47.34	0.00	0.00	0.00

Liabilities ($ Mln)

	Helius Medical Technologies Inc Class A (HSDT)	Penumbra (PEN)	Avantor (AVTR)	Repligen (RGEN)	Glaukos Corp (GKOS)
Shareholder's Funds	165.65	1,583.51	5,835.90	2,112.03	717.27
Minority Interest	0.00	0.00	0.00	0.00	0.00
Non-Current Liabilities	4.21	207.78	4,425.10	705.49	135.53
Current Liabilities	2.16	233.81	1,369.00	132.66	126.73
Total Liabilities	303.93	1,826.52	11,794.70	2,949.70	893.49

Assets ($ Mln)

	Helius Medical Technologies Inc Class A (HSDT)	Penumbra (PEN)	Avantor (AVTR)	Repligen (RGEN)	Glaukos Corp (GKOS)
Non-Current Assets	147.31	648.47	9,037.40	1,749.63	399.88
Current Assets	28.75	1,376.63	2,592.60	1,200.55	579.65
Total Assets	303.93	1,826.52	11,794.70	2,949.70	893.49
Total Debt*	0.00	209.39	3,683.80	690.94	101.98
Net Current Assets	26.59	0.00	1,223.60	1,067.90	452.92

Cashflow ($ Mln)

	Helius Medical Technologies Inc Class A (HSDT)	Penumbra (PEN)	Avantor (AVTR)	Repligen (RGEN)	Glaukos Corp (GKOS)
Cash From Operating Activities	-16.51	238.66	623.80	117.42	-46.34
Cash Flow from Investing Activities	-426.53	-404.59	-130.50	-298.47	-77.61
Cash from Financing Activities	449.24	26.53	-409.40	-15.21	11.89
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	Helius Medical Technologies Inc Class A (HSDT)	Penumbra (PEN)	Avantor (AVTR)	Repligen (RGEN)	Glaukos Corp (GKOS)
ROCE (%)	-27.08	11.76	-5.43	1.79	-22.53
ROE (%)	-67.42	10.27	5.90	1.97	-24.46
ROA (%)	-167.39	5.91	2.57	1.36	-15.48
EBIT Margin (%)	-488.54	13.40	7.39	9.87	-24.51
Net Margin (%)	-1,302.78	10.06	5.08	5.29	-24.60
Cash Profit Margin (%)	--	0.00	0.00	0.00	0.00

Growth Ratios

	Helius Medical Technologies Inc Class A (HSDT)	Penumbra (PEN)	Avantor (AVTR)	Repligen (RGEN)	Glaukos Corp (GKOS)
Revenue Growth (%)	3,992.20	16.98	0.92	16.49	46.94
EBIT Growth (%)	-197.33	11.72	106.97	920.78	-106.70
Net Profit Growth (%)	-638.89	-4.27	510.22	400.42	-93.80
EPS Growth (%)	95.52	-4.95	507.22	394.30	-90.00
Book Value Growth (%)	-13.38	15.61	4.89	2.16	-12.58

Valuation Ratios

	Helius Medical Technologies Inc Class A (HSDT)	Penumbra (PEN)	Avantor (AVTR)	Repligen (RGEN)	Glaukos Corp (GKOS)
Price / Earnings	-1.56	68.93	-14.68	189.42	-34.59
Price / Book Value	0.21	8.19	1.94	4.40	20.01
Dividend Yield (%)	--	0.00	0.00	--	0.00
EV/EBITDA	-1.43	53.91	15.90	50.32	-114.22
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	Helius Medical Technologies Inc Class A (HSDT)	Penumbra (PEN)	Avantor (AVTR)	Repligen (RGEN)	Glaukos Corp (GKOS)
Debt to Equity	0.00	0.00	0.63	0.26	0.00
Short term debt to equity ratio	0.00	0.01	0.01	0.01	0.00
Current Ratio	13.31	5.89	1.89	9.05	4.57
Quick Ratio	13.31	3.92	1.27	7.64	4.09
Interest Coverage	-116.54	165.16	2.81	1.92	-35.23

Operating Efficiency Ratios

	Helius Medical Technologies Inc Class A (HSDT)	Penumbra (PEN)	Avantor (AVTR)	Repligen (RGEN)	Glaukos Corp (GKOS)
Debtors to sales (%)	0.00	12.51	16.92	20.09	21.73
Asset Turnover	0.13	0.59	0.51	0.26	0.63
Receivable days	38.55	46.54	58.79	72.41	60.95
Inventory Days	807.93	331.92	64.13	146.53	193.84
Payable days	1,009.19	26.16	58.13	29.05	60.19
Cash Conversion Cycle	-162.71	352.30	64.79	189.88	194.60

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly